Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Adaptive Platform Treatment Trial for Outpatients with COVID-19 (ACTIV-2)
Outpatient Treatment for COVID-19 (ACTIV-2)
Sponsor:National Institute of Allergy and Infectious Diseases NIAID
Enrolling:Male and Female Patients
Study Length:18 Months
Clinic Visits:11
Minimum Age:18 years old
IRB Number:AAAT6083
U.S. Government ID:NCT04518410
Contact: Bronx Prevention Center: 347-590-7280 / lp2907@cumc.columbia.edu
Additional Study Information:

This study enrolls people recently diagnosed with COVID-19, who are not currently in the hospital. The study tests several different investigational medicines to see if they are safe and can help adults with COVID-19 get better, with the goal of quickly determining those that are safe and effective. Help us to rise above COVID-19!

Do You Qualify?
Are you having any symptoms of COVID-19 (i.e., fever, body aches, chills, loss of taste/smell, etc.)?YesNo
Have you been hospitalized for COVID-19?YesNo
Are you pregnant or breastfeeding? If N/A, select No.YesNo
Submit
Cancel
Investigator
Ellen Morrison, MD, MPH
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Bronx Prevention Center
Email: lp2907@cumc.columbia.edu
Phone: 347-590-7280